Research

(Adobe Stock)
January 16, 2026

Vanderbilt Health team finds potent antibody that neutralizes two dangerous viruses

The single administration of an antibody that provides cross-protection against both RSV and hMPV infection could provide logistical and economic advantages over the need to develop and administer multiple virus-specific monoclonal antibodies.

By Bill Snyder
(iStock)
January 16, 2026

Study finds so-called super agers tend to have at least two key genetic advantages

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

By Paul Govern
January 15, 2026

Nominations sought for 2026 Vanderbilt Prize in Biomedical Science

The prize recognizes a scientist with a national reputation who has a stellar record of research accomplishments and is known for mentoring others in science.

By Bill Snyder
(iStock)
January 15, 2026

Immunometabolism may be a key to controlling sepsis: study

This discovery may lead to new ways to block metabolic changes contributing to excessive and ineffective inflammation, reset the immune system, and bring sepsis under control.

By Bill Snyder
Image of February 2026 cover art for Diabetes created by Christopher Wilson, PhD.
January 14, 2026

Research reveals B cells’ more sinister role in progression of Type 1 diabetes

B cells are immune cells thought to drive the immune system’s attack on insulin-producing beta cells by activating anti-islet T cells.

By Jill Clendening
January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

By Tom Wilemon
January 9, 2026

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023. 
By Guillermo Sanchez, PhD
January 8, 2026

Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.
By Tom Wilemon
January 7, 2026

Study identifies potential target for blood cancer treatment, prevention

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.
By Bill Snyder
January 5, 2026

AI gets risk wrong in the clinic

Large language models have become far better than you at solving math problems but may still be bad at employing probabilistic terms in medical contexts.
By Paul Govern
December 15, 2025

Antibody research may lead to broadly protective flu vaccine

These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu.
By Bill Snyder
December 12, 2025

Lucy Spalluto and Jennifer Lewis awarded $1 million lung cancer screening grant

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.
By Derek Scancarelli
December 10, 2025

Study finds that meditation may help stimulate the brain’s waste removal system, providing restorative benefits like sleep

New research is informing how mindfulness meditation contributes to improvements in cognitive health and may have relevance to treating a range of degenerative brain conditions.
By Evan Dorian